A Randomized, Double-Blind, Placebo-Controlled, Dose-Ran

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in
StatusFinished
Effective start/end date9/26/1312/27/16

Funding

  • SALIX PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.